Fischer Uwe M, Cox Charles S, Allen Steven J, Stewart Randolph H, Mehlhorn Uwe, Laine Glen A
Center for Microvascular and Lymphatic Studies, Department of Surgery and Anesthesiology, the University of Texas-Houston Medical School, USA.
J Thorac Cardiovasc Surg. 2003 Nov;126(5):1483-8. doi: 10.1016/s0022-5223(03)00792-x.
Oxidative stress contributes to myocardial ischemia-reperfusion injury. We hypothesized that administration of the antioxidant N-acetylcysteine would have beneficial effects on myocardial function after cardiopulmonary bypass and cardioplegic arrest.
Anesthetized dogs (n = 18) were instrumented with myocardial ultrasonic crystals and a left ventricular micromanometer. Systolic function was measured by preload recruitable stroke work. Myocardial tissue water was determined by microgravimetry. Treated animals received 100 mg.kg(-1) N-acetylcysteine 10 minutes before initiation of cardiopulmonary bypass followed by 20 mg.kg(-1).h(-1) continuous infusion until 1 hour after cardiopulmonary bypass. After baseline, cardiopulmonary bypass and 2-hour crystalloid cardioplegic arrest was initiated, then reperfusion/rewarming for 40 minutes and separation from cardiopulmonary bypass. Myocardial function parameters and myocardial tissue water were measured at 30, 60, and 120 minutes after cardiopulmonary bypass. Oxidative stress was measured by 8-isoprostane concentrations in the coronary sinus plasma.
Preload recruitable stroke work did not decrease from baseline in the N-acetylcysteine group and was significantly greater in N-acetylcysteine group compared with controls at 30 (104% +/- 9% vs 80% +/- 4%; P <.05) and 120 minutes (98% +/- 7% vs 79% +/- 4%; P <.05) after cardiopulmonary bypass. Concentrations of 8-isoprostane in the coronary sinus plasma of the control dogs were significantly higher 30 minutes after cardiopulmonary bypass compared with baseline but were unchanged in the N-acetylcysteine group. Myocardial edema resolution was significantly greater in the N-acetylcysteine group at 30 minutes after cardiopulmonary bypass compared with control (-2.5% +/- 0.7% vs -0.3% +/- 0.5% myocardial tissue water; P <.05).
Administration of the antioxidant N-acetylcysteine preserves systolic function and enhances myocardial edema resolution after cardiopulmonary bypass/cardioplegic arrest. Furthermore, oxidative stress was significantly reduced in the treated animals. Therefore, our findings support the hypothesis that oxidative stress is the main cause for myocardial dysfunction after ischemia-reperfusion.
氧化应激导致心肌缺血 - 再灌注损伤。我们假设给予抗氧化剂N - 乙酰半胱氨酸对体外循环和心脏停搏后的心肌功能有益。
对18只麻醉犬植入心肌超声晶体和左心室微测压计。通过前负荷可招募的搏功来测量收缩功能。通过微量重力测定法测定心肌组织含水量。治疗组动物在体外循环开始前10分钟接受100mg·kg⁻¹的N - 乙酰半胱氨酸,随后以20mg·kg⁻¹·h⁻¹持续输注直至体外循环后1小时。记录基线值后,开始体外循环和2小时晶体心脏停搏,然后再灌注/复温40分钟并脱离体外循环。在体外循环后30、60和120分钟测量心肌功能参数和心肌组织含水量。通过冠状窦血浆中8 - 异前列腺素浓度测量氧化应激。
N - 乙酰半胱氨酸组前负荷可招募的搏功未从基线下降,且在体外循环后30分钟(104%±9%对80%±4%;P<.05)和120分钟(98%±7%对79%±4%;P<.05)时,N - 乙酰半胱氨酸组显著高于对照组。与基线相比,对照组犬冠状窦血浆中8 - 异前列腺素浓度在体外循环后30分钟显著升高,但在N - 乙酰半胱氨酸组中未发生变化。与对照组相比,N - 乙酰半胱氨酸组在体外循环后30分钟时心肌水肿消退更明显(心肌组织含水量为 - 2.5%±0.7%对 - 0.3%±0.5%;P<.05)。
给予抗氧化剂N - 乙酰半胱氨酸可在体外循环/心脏停搏后维持收缩功能并增强心肌水肿消退。此外,治疗组动物的氧化应激显著降低。因此,我们的研究结果支持氧化应激是缺血 - 再灌注后心肌功能障碍主要原因的假设。